Article | March 16, 2020

Learning To Listen: Voice Of The Patient Grows Louder In Product Development

By Katharine Chorlton

Meet Needs Of Medicaid Patients

Days before Christmas 2017, a nationwide call went out requesting nominations of patients and caregivers to join a new public/private-sponsored Patient Engagement Collaborative.

Among the promised duties for this yet-to-be-filled body of 16 patient community representatives: Propose new collaboration models in which patients and patient advocates are partners in healthcare product development and U.S. Food and Drug Administration product reviews.

The collaborative’s creation, a little more than a year after the 21st Century Cures Act became law in the United States, is the latest step in an accelerating patient-centered drug and device development movement. This worldwide effort is being fueled by ever-improving consumer-controlled social and health data technology, advancements in personal genetic understanding, and increased healthcare cost-sharing in some quarters. Patient-driven changes are systematically beginning to inject more than token patient participation and viewpoints into all stages of drug and device development and slowly, but methodically, chipping away at the clinically isolated way drugs and medical devices are developed.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: